z-logo
open-access-imgOpen Access
Reversible Posterior Leukoencephalopathy Syndrome in a Patient Treated With Ustekinumab
Author(s) -
David Gratton
Publication year - 2011
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archdermatol.2011.161
Subject(s) - medicine , posterior reversible encephalopathy syndrome , ustekinumab , magnetic resonance imaging , headaches , vomiting , radiology , emergency department , pediatrics , surgery , dermatology , infliximab , disease , psychiatry
Reversible posterior leukoencephalopathy syndrome (RPLS) is a rare, generally reversible neurologic syndrome that is diagnosed based on characteristic clinical and radiologic findings.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom